Understanding how cells communicate between their nucleus and cytoplasm
Structure-Function of Nucleo-Cytoplasmic Communication
This study is looking at how cells talk to each other by examining the tiny structures that help them communicate, which is important because problems with this communication can lead to diseases like muscular dystrophies and cancers, and understanding it better could help find new ways to treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10910035 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that allow communication between the nucleus and cytoplasm of eukaryotic cells, focusing on the structures involved in this process. By using advanced imaging techniques like cryo-electron microscopy, the researchers aim to visualize the protein complexes that facilitate this communication. Understanding these structures is crucial, as dysfunction in this communication is linked to various diseases, including certain muscular dystrophies and cancers. The findings could lead to new insights into how these diseases develop and how they might be treated.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to nucleo-cytoplasmic communication dysfunction, such as Emery-Dreifuss Muscular Dystrophy or certain cancers.
Not a fit: Patients with conditions unrelated to cellular communication or those not affected by the diseases being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases caused by dysfunctional nucleo-cytoplasmic communication.
How similar studies have performed: Other research has shown promising results in understanding cellular communication mechanisms, making this approach both relevant and potentially impactful.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Schwartz, Thomas — Massachusetts Institute of Technology
- Study coordinator: Schwartz, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.